baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ANI Pharmaceuticals/ US00182C1036 /

13/05/2024 21:59:53	Chg. -0.53	Volume	Bid-	Ask-	High	Low
67.48USD	-0.78%	4,714 Turnover: 322,016.19	-Bid Size: -	-Ask Size: -	69.53	67.33

GlobeNewswire 10/05 ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance

GlobeNewswire 01/05 ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

GlobeNewswire 18/04 ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET

GlobeNewswire 09/04 ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension

GlobeNewswire 04/04 ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis

GlobeNewswire 03/04 ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium

GlobeNewswire 27/03 ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP

GlobeNewswire 29/02 ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides ...

GlobeNewswire 20/02 ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

GlobeNewswire 29/01 ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Con...

GlobeNewswire 23/01 ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP

GlobeNewswire 16/01 ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP

GlobeNewswire 22/11/2023 ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire 08/11/2023 ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Gu...

GlobeNewswire 30/10/2023 ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

GlobeNewswire 25/10/2023 ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m...

GlobeNewswire 02/10/2023 ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Pur...

GlobeNewswire 18/09/2023 ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

GlobeNewswire 12/09/2023 ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP

GlobeNewswire 28/08/2023 ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%

GlobeNewswire 24/08/2023 ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire 23/08/2023 ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors

GlobeNewswire 20/12/2021 Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tabl...

GlobeNewswire 11/12/2021 Annual Changes to the Nasdaq Biotechnology Index

GlobeNewswire 07/12/2020 Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors

ANI Pharmaceuticals/ US00182C1036 /

If you wish to receive reply to your feedback, please provide your email address.